Company profile: Cosman Medical
1.1 - Company Overview
Company description
- Provider of radiofrequency (RF) generators, electrodes, and cannulae for neurosurgery and pain management in interventional anesthesiology and podiatry, leveraging RF nerve ablation with a 60-year track record in medicine.
Products and services
- Cialis: Extended-duration ED drug that enhances blood flow to the penis, enabling an erection during sexual arousal, with effects lasting up to 36 hours for sustained activity
- Levitra: Pharmacological ED treatment that increases penile blood flow, helping achieve and maintain an erection during sexual activity for reliable arousal-responsive performance
- Viagra: Therapeutic ED medication that increases blood flow to the penis, facilitating an erection in response to sexual stimulation for improved function during intimate engagement
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cosman Medical
Adapt Pharma
HQ: United States
Website
- Description: Provider of therapeutic treatments for patients with special medical conditions, including NARCAN (naloxone hydrochloride) Nasal Spray, an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adapt Pharma company profile →
NeuroNexus
HQ: United States
Website
- Description: Provider of neural interface technology, components, and systems for neuroscience and clinical applications, including high-density SiNAPS CMOS probes; X-Series modular connector packages; X-Headstage implantable devices for recording and stimulation; XDAQ Core and XDAQ One electrophysiology data acquisition systems with IO Expander; and Z-Coat site coating to enhance probe performance in brain tissue.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuroNexus company profile →
IntraBio
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies and candidates, including IB1001 (orally administered N-Acetyl-Leucine) for rare neurological disorders such as NPC, GM1/GM2 gangliosidosis and inherited cerebellar ataxias; IB2000 and IB5000 for Ménière’s disease with clinical efficacy and safety in observational studies; IB3000 (NAADP analogues/agonists) with pre-clinical potential for Type 2 Diabetes, autism and neurodegenerative disorders; IB4000 (UDCA) for NPC liver dysfunction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IntraBio company profile →
Psyence Biomed
HQ: Canada
Website
- Description: Provider of nature-derived psilocybin-based psychedelic medicines focused on mental health disorders in palliative care. Conducts Phase IIb clinical trials of natural psilocybin for Adjustment Disorder with psychotherapy and varied dosages, and plans a clinical trial for Alcohol Use Disorder with a focus on Substance Use Disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Psyence Biomed company profile →
Oligomerix
HQ: United States
Website
- Description: Provider of target identification and validation technologies to enhance drug discovery for neurodegenerative diseases, and tau-targeting therapeutics including OLX-07010, a Phase 1 small molecule inhibitor of tau self-association, a series of tau small molecule inhibitors, and companion biomarker programs to aid diagnosis and monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oligomerix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cosman Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cosman Medical
2.2 - Growth funds investing in similar companies to Cosman Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cosman Medical
4.2 - Public trading comparable groups for Cosman Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →